ArticleJAMA network open2022

Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022.

Kristina L Bajema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.